Practical guidelines for the acute emergency sedation of the severely agitated older patient

Internal Medicine Journal

Volumn 41, Issue 9, 2011, Pages 651-657

  Peisah, C ^a,b   Chan, D K Y ^a,b   Mckay, R ^a,c   Kurrle, S E ^d,e   Reutens, S G ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^c South Western Sydney Local Health Network   (Australia)

^d University of Sydney   (Australia)

^e HORNSBY KU RING GAI HOSPITAL   (Australia)

Author keywords

Agitation; Elderly; Sedation

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CHLORPROMAZINE; DIAZEPAM; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; RISPERIDONE; THIAMINE; ZIPRASIDONE;

AGED HOSPITAL PATIENT; AGITATION; ALCOHOL WITHDRAWAL; ARTICLE; BRADYCARDIA; CONSCIOUSNESS DISORDER; DELIRIUM; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DYSTONIA; EMERGENCY CARE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPOTENSION; IMMOBILIZATION; INFORMED CONSENT; LOW DRUG DOSE; PARKINSONISM; PATIENT ASSESSMENT; PATIENT SAFETY; PHYSICAL RESTRAINT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RESPIRATION DEPRESSION; RISK BENEFIT ANALYSIS; SEDATION; SIDE EFFECT; VISUAL HALLUCINATION;

AGE FACTORS; AGED; CONSCIOUS SEDATION; EMERGENCY MEDICAL SERVICES; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSYCHOMOTOR AGITATION; SEVERITY OF ILLNESS INDEX;

EID: 80052573513     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2011.02560.x     Document Type: Article

References (31)

1. Battaglia J, Lindborg SR, Alaka K, Meehan K, Wright P. Calming versus sedative effects of intramuscular olanzapine in agitated patients. Am J Emerg Med 2003; 21: 192-8.
2. Eeles EM, Hubbard RE, White SV, O'Mahony MS, Savva GM, Bayer AJ. Hospital use, institutionalisation and mortality associated with delirium. Age Ageing 2010; 39: 470-75.
3. Greco KE, Tune LE, Brown FW, Van Horn WA, Van Horn WA. A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients. J Clin Psychiatry 2005; 66: 928-9.
4. Nassisi D, Korc B, Hahn S, Bruns J Jr, Jagoda A. The evaluation and management of the acutely agitated elderly patient. Mt Sinai J Med 2006; 73: 976-84.
5. Tropea J. Policy and Practice Update. Clinical practice guidelines for the management of delirium in older people in Australia. Australas J Ageing 2008; 27: 150-56.
6. Cohen-Mansfield J. Non-phamacological interventions for inappropriate behaviours in dementia: a review, summary and critique. Am J Geriatr Psychiatry 2001; 9: 361-81.
7. Inouye SK. Delirium in older persons. N Engl J Med 2006; 354: 1157-65.
8. Siddiqi N, Stockdale R, Britton AM, Holmes J. Interventions for preventing delirium in hospitalised patients. Cochrane Database Syst Rev 2007; 18: CD005563.
9. Marcantonio ER, Flacker JM, Wright RJ, Resnick NM. Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc 2001; 49: 516-22.
10. Potter J, George J. Guideline Development Group. The prevention, diagnosis and management of delirium in older people: concise guidelines. Clin Med 2006; 6: 303-8.
11. Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol 2009; 5: 210-20.
12. Saxena S, Lawley D. Delirium in the elderly: a clinical review. Postgrad Med J 2009; 85: 405-13.
13. Australian Society for Geriatric Medicine. Position Statement No 13. Delirium in Older People. 2006 [cited 2011 Aug 2]. Available from URL.
14. Lu JH, Chan DKY, O'Rourke F, Ong B, Shen Q, Reutens S etal. Management and outcomes of delirious patients with hyperactive symptoms in a secured behavioural unit jointly used by geriatricians and psychogeriatricians. Arch Gerontol Geriatr 2011; 52: 66-70.
15. Flaherty JH, Steele DK, Chibnall JT, Vasudevan VN, Bassil N, Vegi S. An ACE unit with a delirium room may improve function and equalize length of stay among older delirious medical inpatients. J Gerontol A Biol Sci Med Sci 2010; 65: 1387-92.
16. Capezuti E. Minimising the use of restrictive devices in dementia patients at risk of falling. Nurs Clin North Am 2004; 39: 625-47.
17. Lonergan E, Britton AM, Luxenberg J. Antipsychotics for delirium. Cochrane Database Syst Rev 2007; 2: CD005594.
18. Lonergan E, Luxenberg J, Colford J. Haloperidol for agitation in dementia. Cochrane Database Syst Rev 2002; 2: CD002852.
19. Weintraub D, Hurtig HI. Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies. Am J Psychiatry 2007; 164: 1491-8.
20. Meehan KM, Wang H, David SR, Nisivoccia JR, Jones B, Beasley CM Jr etal. Comparison of rapidly acting intramuscular olanzapine, lorazepam and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology 2002; 26: 494-504.
21. MIMS Full Prescribing information. [Olanzapine]. St Leonards: UBM Medica Australia Pty Ltd.
22. Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R etal. A randomized placebo, controlled trial of risperidone for the treatment pf agitation and psychosis of dementia. J Clin Psychiatry 2003; 64: 134-43.
23. Suh GH, Son HG, Ju YS, Jcho KH, Yeon BK, Shin YM etal. A randomized, double-blind, cross-over comparison of risperdone and haloperidol in Korean dementia patients with behavioral disturbances. Am J Geriatr Psychiatry 2004; 12: 509-16.
24. Liu CY, Juang YY, Liang HY, Lin NC, Yeh EK. Efficacy of risperidone in treating the hyperactive symptoms of delirium. Int Clin Psychopharmacol 2004; 19: 165-8.
25. Kohen I, Preval H, Southard R, Francis A. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service. Am J Geriatr Pharmacother 2005; 3: 240-45.
26. Oechsner M, Korchounov A. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease? Hum Psychopharmacol 2005; 20: 203-5.
27. Tahir TA, Eeles E, Karapareddy V, Muthuvelu P, Chapple S, Phillips B etal. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res 2010; 69: 485-90.
28. Battaglia J, Moss S, Rush J, Kang J, Mendoza R, Leedom l etal. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med 1997; 15: 335-40.
29. Bieniek SA, Ownby RL, Penalver A, Dominguez RA. A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy 1998; 18: 57-62.
30. Mental Health and Drug and Alcohol Office. Mental Health for Emergency Departments - A Reference Guide. Sydney: NSW Department of Health; 2009.
31. Cannon ME, Sprivulis P, McCarthy J. Restraint practices in Australasian emergency departments. Aust NZ J Psych 2001; 35: 464-7.